Connect with us

Health

New Report Urges A Stop To Anti-Vape Hysteria – – VENTS Magazine

Published

 on


1 min ago
Miscellaneous, Other Stuff

Evidence, alarm, and the debate over e-cigarettes. That is the title of a new analysis published in the journal Science. The analysis was a collaboration of five prominent scientists from a range of disciplines and universities. Experts focused on the potential harm of the anti-vaping hysteria that has gripped the discussion in the latter half of 2019. As a result of the hysteria, several states have enacted vaping and flavor bans. The fear is that sweeping bans could prove detrimental to public health.

The Science vaping analysis concluded that if a significant number of Americans switched from smoking cigarettes to vaping nicotine, 1.6 million lives could be saved. Smoking still kills 480,000 Americans every year. This century, smoking will claim one billion lives around the world. The horrific death toll caused by smoking needs to be factored into any proposed vaping legislation.

  • “Restricting access and appeal among less harmful vaping products out of an abundance of caution while leaving deadly combustible products on the market does not protect public health. It threatens to derail a trend that could hasten the demise of cigarettes, poised to take a billion lives this century.” – From Evidence, Alarm, and the Debate Over E-cigarettes.

The analysis was published in response to the alarm raised over an outbreak of a mysterious lung illness that was attributed to vaping and to a dramatic increase in underage experimentation with vaping. The lung illness outbreak has since been traced to black-market THC products. The CDC has positively identified vitamin E acetate as the additive to THC oil that caused the outbreak of illnesses. Vitamin E acetate is not used in e-cigarettes or nicotine vape liquids.

However, the increase in underage vaping remains a serious concern. Underage past-30 day e-cigarette use rates among teens increased from 11% in 2017 to 28% in 2019. The analysis suggests that “threading the needle” between prevention and access is the key. The UK model is cited because while e-cigs are available to adult smokers, underage experimentation rates are stable. But, thus far in the United States the proposed solutions may do more harm than good.

On September 11, the President and Health and Human Services Secretary Alex Azar announced a ban on all flavored electronic cigarettes except for tobacco flavors. While the White House has since pulled back on a flavor ban, the ultimate outcome of national e-cigarette regulation is unknown. Despite a lack of final FDA guidance, many states enacted their own flavor bans. New York, Michigan Wisconsin, and others announced a ban on all vape flavors. Massachusetts Governor Charlie Baker enacted a complete ban on all vapor products. However, Governor Baker’s ban left cigarettes untouched. In New York, Governor Cuomo’s ban outlawed menthol-flavored e-cigs but left menthol cigarettes on the shelves. These are exactly the type of bans that are cause for concern according to the Science analysis.

  • “We share strong concern about the large surge in youth vaping (some call it an epidemic and point to studies of a possible but unproven causal gateway into smoking) and we promote harm minimization and management. Yet we suggest that careful analysis of all the data in context indicates that the net benefits of vaped nicotine products outweigh the feared harms to youth” From Science Evidence, Alarm, and the Debate Over E-cigarettes

The analysis revealed that while flavors may play a role in attracting underage experimentation, flavors are also vital to assist smokers to switch to vaping. While tobacco flavors are the usual starting point for a smoker switching to e-cigs, it is pointed out in the research that adult smokers generally transition to menthol and then to other flavors to help refrain from smoking cigarettes.

The Path Forward For Vaping

The researchers involved in the analysis derived a number of policy prescriptions designed to ensure access for adults while preventing underage use. The implementation and enforcement of a national 21 age limit for both nicotine and THC products. In addition, the analysis recommends the use of taxation on e-cigarettes but at a lower rate than tobacco cigarettes. In other words, e-cigarettes should not be cheap, but they should cost less than cigarettes.

Here is the list of recommendations proposed by researchers in Science:

  • No youth under 21 should use any form of nicotine

  • No youth under 21 should use any current form of THC

  • Taxation on vapor products but a lower rate than cigarettes

  • Communicate that vaping reduces risk compared to smoking

  • No predatory marketing to youth

  • Implement product quality standards

It is interesting to note that the FDA does not currently allow any e-cigarette company to claim that vaping is less harmful than smoking. However, researchers cite the UK example where Public Health England has determined that vaping is 95% safer than smoking.

Ensuring all purchasers are at least 21 years of age is crucial to the plan. The age limit must be enforced. Online sales, despite often the target of politicians, are actually the most secure. Age verification technology may hold the key to properly enforcing the 21 age limit. Of course, the technology must be current. For example, Mig Vapor, an independent American vape company, uses a multi-layered, AI powered age verification technology.

The overall summary of the analysis is that the threat from smoking is far from over. American families lose 480,000 loved ones every year from smoking. The progress we have made combatting tobacco harm could be derailed by policy decisions made in a state of alarm as opposed to reason. Finally, the researchers point out that it is worth the effort to thread the needle and to find a balance. Because there is a way to ensure access to vapor products for adult smokers and curb youth experimentation with e-cigarettes at the same time.

Check Also



If you’re planning to go away to college, then finding the right student housing for …

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Biden’s vaccine pledge ups pressure on rich countries to give more

Published

 on

The United States on Thursday raised the pressure on other Group of Seven leaders to share their vaccine hoards to bring an end to the pandemic by pledging to donate 500 million doses of the Pfizer coronavirus vaccine to the world’s poorest countries.

The largest ever vaccine donation by a single country will cost the United States $3.5 billion but Washington expects no quid pro quo or favours for the gift, a senior Biden administration official told reporters.

U.S. President Joe Biden‘s move, on the eve of a summit of the world’s richest democracies, is likely to prompt other leaders to stump up more vaccines, though even vast numbers of vaccines would still not be enough to inoculate all of the world’s poor.

G7 leaders want to vaccinate the world by the end of 2022 to try to halt the COVID-19 pandemic that has killed more than 3.9 million people and devastated the global economy.

A senior Biden administration official described the gesture as a “major step forward that will supercharge the global effort” with the aim of “bringing hope to every corner of the world.” “We really want to underscore that this is fundamentally about a singular objective of saving lives,” the official said, adding that Washington was not seeking favours in exchange for the doses.

Vaccination efforts so far are heavily correlated with wealth: the United States, Europe, Israel and Bahrain are far ahead of other countries. A total of 2.2 billion people have been vaccinated so far out of a world population of nearly 8 billion, based on Johns Hopkins University data.

U.S. drugmaker Pfizer and its German partner BioNTech have agreed to supply the U.S. with the vaccines, delivering 200 million doses in 2021 and 300 million doses in the first half of 2022.

The shots, which will be produced at Pfizer’s U.S. sites, will be supplied at a not-for-profit price.

“Our partnership with the U.S. government will help bring hundreds of millions of doses of our vaccine to the poorest countries around the world as quickly as possible,” said Pfizer Chief Executive Albert Bourla.

‘DROP IN THE BUCKET’

Anti-poverty campaign group Oxfam called for more to be done to increase global production of vaccines.

“Surely, these 500 million vaccine doses are welcome as they will help more than 250 million people, but that’s still a drop in the bucket compared to the need across the world,” said Niko Lusiani, Oxfam America’s vaccine lead.

“We need a transformation toward more distributed vaccine manufacturing so that qualified producers worldwide can produce billions more low-cost doses on their own terms, without intellectual property constraints,” he said in a statement.

Another issue, especially in some poor countries, is the infrastructure for transporting the vaccines which often have to be stored at very cold temperatures.

Biden has also backed calls for a waiver of some vaccine intellectual property rights but there is no international consensus yet on how to proceed.

The new vaccine donations come on top of 80 million doses Washington has already pledged to donate by the end of June. There is also $2 billion in funding earmarked for the COVAX programme led by the World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI), the White House said.

GAVI and the WHO welcomed the initiative.

Washington is also taking steps to support local production of COVID-19 vaccines in other countries, including through its Quad initiative with Japan, India and Australia.

(Reporting by Steve Holland in St. Ives, England, Andrea Shalal in Washington and Caroline Copley in Berlin; Writing by Guy Faulconbridge and Keith Weir;Editing by Leslie Adler, David Evans, Emelia Sithole-Matarise, Giles Elgood and Jane Merriman)

Continue Reading

Health

Vaccines donated by the United States and China

Published

 on

Both the United States and China have pledged large donations of COVID-19 vaccines to countries around the world. Washington has promised 80 million doses, three-quarters of which will be delivered via the international vaccine initiative COVAX, in what has been seen as an effort to counter China’s widening vaccine diplomacy. It began deliveries last week.

China had shipped vaccines to 66 countries in the form of aid, according to state news agency Xinhua. Beijing has not disclosed an overall figure for its donations but Reuters calculations based on publicly available data show at least 16.57 million doses have been delivered. China has also pledged to supply 10 million doses to COVAX.

VACCINES DONATED BY U.S. (plan for the first 25 mln):

Regional partners and priority recipients

COUNTRY/TERRITORY PLEDGED DELIVERED

Including Canada, Mexico, 1 mln to S.Korea in June

South Korea, West Bank and

Gaza, Ukraine, Kosovo,

Haiti, Georgia, Egypt,

Jordan, India, Iraq, Yemen,

United Nations

TOTAL 6 mln 1 mln

Allocations through COVAX

South and Central America

COUNTRY/TERRITORY PLEDGED DELIVERED

Brazil, Argentina, Colombia,

Costa Rica, Peru, Ecuador,

Paraguay, Bolivia,

Guatemala, El Salvador,

Honduras, Panama, Haiti,

Dominican Republic and other

Caribbean Community

(CARICOM) countries

TOTAL 6 mln

Asia

COUNTRY/TERRITORY PLEDGED DELIVERED

India, Nepal, Bangladesh,

Pakistan, Sri Lanka,

Afghanistan, Maldives,

Malaysia, Philippines,

Vietnam, Indonesia,

Thailand, Laos, Papua New

Guinea, Taiwan, and the

Pacific Islands

TOTAL 7 mln

Africa

COUNTRY/TERRITORY PLEDGED DELIVERED

To be selected in

coordination with the

African Union

TOTAL 5 mln

VACCINES DONATED BY CHINA (source – Reuters calculations and official data):

Asia Pacific

COUNTRY/TERRITORY PLEDGED DELIVERED

Afghanistan 400,000

Bangladesh Second batch of First batch of 500,000 delivered

600,000 on May 12

Brunei 52,000 in Feb

Cambodia 1.7 mln as of April 28

Kyrgyzstan 150,000 in March

Laos 300,000 in Feb

800,000 in late March

300,000 in late April

Maldives 200,000 in early March

Mongolia 300,000 in late February

Myanmar 500,000 in early May

Nepal 800,000 in late March

1 mln in early June

Pakistan 500,000 in early Feb

250,000 in Feb

500,000 in March

Philippines 600,000 in late Feb

400,000 in late March

Sri Lanka 600,000 at end March

500,000 in late May

Thailand 500,000 in May

500,000 in June

Timor-Leste 100,000 100,000 in early June

TOTAL 11.052 million

Africa

COUNTRY/TERRITORY PLEDGED DELIVERED

Angola 200,000 in late March

Algeria 200,000 200,000 in Feb

Botswana 200,000 in April

Cameroon 200,000 in April

Congo 100,000 100,000 in March

Egypt 600,000 in March

Ethiopia 300,000 in late March

Equatorial Guinea 100,000 in Feb

Guinea 200,000 in early March

Mozambique 200,000 in late Feb

Namibia 100,000 by early April

Niger 400,000 in late March

Sierra Leone 240,000 by late May

Togo 200,000 in April

Uganda 300,000

Zimbabwe 200,000 in Feb

200,000 in March

100,000 in May

TOTAL 3.74 million

South America

COUNTRY/TERRITORY PLEDGED DELIVERED

Bolivia 100,000 in late Feb

100,000 in late March

Venezuela 500,000 in early March

TOTAL 700,000

Europe & Middle East

COUNTRY/TERRITORY PLEDGED DELIVERED

Belarus 100,000 in Feb

300,000 in May

Georgia 100,000 at end April

Iran 250,000 at end February

Iraq 50,000 in early March

Montenegro 30,000 in early March

North Macedonia 100,000 in May

Syria 150,000 in late April

TOTAL 1.08 million

 

(Reporting by Roxanne Liu and Ryan Woo in Beijing and Cooper Inveen in Dakar; Additional reporting by MacDonald Dzirutwe in Harare, Asif Shahzad in Islamabad, Gopal Sharma in Kathmandu; Editing by Edwina Gibbs)

Continue Reading

Health

Coronavirus Worldwide right now

Published

 on

Here’s what you need to know about the coronavirus now:

Australia’s Melbourne to exit lockdown

Australia’s second largest city Melbourne will exit a hard lockdown as planned on Thursday night, Victoria state authorities said, although some restrictions on travel and gatherings would likely remain for another week.

After two weeks in a strict lockdown that forced people to remain at home except for essential business, Melbourne’s five million residents will get more freedom to step outside from 11:59 p.m. local time (1359 GMT) on Thursday.

However, people must stay within 25 km (15 miles) of their homes, officials said, in an effort to stop transmission during an upcoming long weekend. There will also be a total ban on house gatherings and masks will be mandatory indoors.

Deliveries of Thai-made AstraZeneca vaccines delayed

Malaysia and Taiwan are expecting deliveries of AstraZeneca vaccines manufactured in Thailand to be delayed, officials said, the latest countries to report a holdup with orders from the Thai plant.

The delay comes amid concerns over AstraZeneca’s distribution plans in Southeast Asia, which depends on 200 million doses made by Siam Bioscience, a company owned by Thailand’s king that is making vaccines for the first time.

Any questions about Siam Bioscience meeting production targets are sensitive because King Maha Vajiralongkorn is its sole owner. Insulting Thailand’s monarchy is a crime punishable by up to 15 years in prison.

Indonesia aims to speed up vaccinations

President Joko Widodo said on Wednesday he hoped Indonesia’s vaccination rollout will hit one million shots a day by July, as authorities opened up inoculations to anyone aged over 18 in Jakarta to contain increased transmission in the capital.

Health officials in the world’s fourth most populous country, which aims to vaccinate 181.5 million people by next year, are trying to speed up the rollout after facing some supply issues.

The president said he wanted vaccinations to hit a targeted 700,000 doses a day this month and then rise again.

Singapore finds Delta most prevalent among variants

Singapore has found the Delta variant of the coronavirus to be the most prevalent among local cases of variants of concern (VOCs), according to health ministry data, highlighting its level of infectiousness.

There were 449 local cases with VOCs as of May 31, of which 428 were the Delta variant first detected in India and nine of the Beta variant first identified in South Africa.

Singapore reported its 34th death due to COVID-19, taking its toll from the pandemic beyond the 33 casualties recorded during the 2003 Severe Acute Respiratory Syndrome outbreak.

U.S. forming expert groups on lifting travel restrictions

The Biden administration is forming expert working groups with Canada, Mexico, the European Union and the United Kingdom to determine how best to safely restart travel after 15 months of pandemic restrictions, a White House official said on Tuesday.

Another U.S. official said the administration will not move quickly to lift orders that bar people from much of the world from entering the United States because of the time it will take for the groups to do their work.

The groups will be led by the White House COVID Response Team and the National Security Council and include the Centers for Disease Control and other U.S. agencies.

 

(Compiled by Linda Noakes; Editing by Giles Elgood)

Continue Reading

Trending